VICO — Vicore Pharma Holding AB Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeSmall CapMomentum Trap

Annual balance sheet for Vicore Pharma Holding AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Short Term Investments
Cash and Short Term Investments	371	262	483	1,156	1,167
Net Total Accounts Receivable
Net Total Receivables	1.42	2.18	3.24	19.8	16.2
Prepaid Expenses
Total Current Assets	378	270	496	1,203	1,217
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.401	0.117	0.025	0	—
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	451	338	498	1,203	1,219
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	65.7	46.4	41	72.9	118
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	67.9	48.9	42.4	73.8	123
Common Stock
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	383	289	455	1,129	1,095
Total Liabilities & Shareholders' Equity	451	338	498	1,203	1,219
Total Common Shares Outstanding